Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01858558 |
|---|---|
| Brief Title: | Tadalafil and Lenalidomide Maintenance With or Without Activated Marrow Infiltrating Lymphocytes (MILs) in High Risk Myeloma |
| First Submitted : | May 14, 2013 |
| First Submitted that Met QC Criteria : | May 16, 2013 |
| First Posted : | May 21, 2013 (Estimate) |
| Results First Submitted : | June 11, 2020 |
| Results First Submitted that Met QC Criteria : | June 11, 2020 |
| Results First Posted : | June 29, 2020 |
| Last Update Submitted that Met QC Criteria : | June 11, 2020 |
| Last Update Posted : | June 29, 2020 |